Clinical improvement in antiphospholipid syndrome after rituximab therapy.
Adamson
Rosemary
R
Lupus Research Unit, The Rayne Institute, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK. r.adamson.98@cantab.net
Sangle
Shirish
S
Kaul
Arvind
A
Hughes
Graham R V
GR
D'Cruz
David P
DP
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D016736:Antiphospholipid Syndrome / Q000188:drug therapy*; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000069283:Rituximab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab